Here you’ll find 45 Medications that start with V that begin with V, organized from “vaccinia vaccine (smallpox)” to “vosoritide”. Many entries are vaccines, antivirals, or cardiovascular and metabolic medicines used commonly in clinical care around the world.
Medications that start with V are drugs whose generic names begin with the letter V. They range from historic vaccines like the vaccinia vaccine to modern targeted therapies such as vosoritide.
Below you’ll find the table with Generic name, Drug class, Common uses, Common side effects, and Brand names.
Generic name: Shows the official generic name so you can identify the medicine precisely and compare information across sources.
Drug class: Lists the therapeutic class so you can understand the medicine’s general mechanism and similar drugs at a glance.
Common uses: Summarizes primary indications so you can quickly see why the medicine is prescribed in everyday care.
Common side effects: Notes frequent side effects so you can anticipate common reactions and discuss them with your care team.
Brand names: Provides widely used brand names so you can recognize trade labels you may encounter at the pharmacy.
Medications that start with V
Name | Brand names | Drug class | Common use(s) |
---|---|---|---|
valacyclovir | Valtrex | Antiviral (nucleoside analog) | Herpes simplex, shingles, chickenpox |
valproic acid | Depakene, Stavzor, Depacon | Antiepileptic, mood stabilizer | Seizures, bipolar disorder, migraine prevention |
valsartan | Diovan | Angiotensin receptor blocker (ARB) | Hypertension, heart failure, post‑MI |
vancomycin | Vancocin | Glycopeptide antibiotic | Serious Gram‑positive infections, C. difficile (oral) |
vardenafil | Levitra, Staxyn | PDE5 inhibitor | Erectile dysfunction |
varenicline | Chantix | Nicotine receptor partial agonist | Smoking cessation |
varicella vaccine | Varivax, ProQuad | Live attenuated vaccine | Prevention of chickenpox (varicella) |
vaccinia vaccine (smallpox) | ACAM2000, Imvamune/Imvanex | Live vaccine (vaccinia virus) | Smallpox prevention, biodefense |
varicella zoster immune globulin | VariZIG | Passive immunoglobulin | Post‑exposure prophylaxis for varicella |
vasopressin | Vasostrict | Vasoconstrictor, antidiuretic hormone analog | Vasodilatory shock, diabetes insipidus (some forms) |
vemurafenib | Zelboraf | BRAF V600 inhibitor (targeted therapy) | BRAF‑mutant metastatic melanoma |
venlafaxine | Effexor | SNRI antidepressant | Depression, anxiety disorders |
venetoclax | Venclexta | BCL‑2 inhibitor (antineoplastic) | Chronic lymphocytic leukemia, AML |
verapamil | Calan, Isoptin | Calcium channel blocker (non‑dihydropyridine) | Hypertension, arrhythmia, angina |
vericiguat | Verquvo | Soluble guanylate cyclase stimulator | Chronic heart failure with reduced EF |
vildagliptin | Galvus | DPP‑4 inhibitor (antidiabetic) | Type 2 diabetes mellitus |
vilazodone | Viibryd | SSRI + 5‑HT1A partial agonist | Major depressive disorder |
vincristine | Oncovin | Vinca alkaloid chemotherapy | Various leukemias and lymphomas |
vinblastine | Velban | Vinca alkaloid chemotherapy | Hodgkin lymphoma, testicular cancer |
vinorelbine | Navelbine | Vinca alkaloid chemotherapy | Non‑small cell lung cancer, breast cancer |
vinflunine | Javlor | Vinca‑derived chemotherapy | Advanced urothelial carcinoma (some regions) |
voriconazole | Vfend | Triazole antifungal | Invasive fungal infections (Aspergillus, Candida) |
vosoritide | Voxzogo | CNP analog (peptide therapy) | Achondroplasia (growth disorder) |
voclosporin | Lupkynis | Calcineurin inhibitor | Immunosuppression for lupus nephritis |
valganciclovir | Valcyte | Antiviral (ganciclovir prodrug) | CMV treatment and prevention |
valrubicin | Valstar | Anthracycline (intravesical chemo) | Bladder cancer (intravesical therapy) |
vedolizumab | Entyvio | Anti‑integrin monoclonal antibody | Ulcerative colitis, Crohn’s disease |
viltolarsen | Viltepso | Antisense oligonucleotide | Duchenne muscular dystrophy (exon skipping) |
vorinostat | Zolinza | Histone deacetylase inhibitor | Cutaneous T‑cell lymphoma |
vorapaxar | Zontivity | PAR‑1 receptor antagonist (antiplatelet) | Secondary prevention of thrombotic events |
vortioxetine | Trintellix | Serotonin modulator and stimulator | Major depressive disorder |
valbenazine | Ingrezza | VMAT2 inhibitor | Tardive dyskinesia |
viloxazine | Qelbree | Norepinephrine modulator | ADHD (children and adults) |
velpatasvir | Epclusa (component), Vosevi (combo) | NS5A inhibitor (HCV antiviral) | Chronic hepatitis C (various genotypes) |
vandetanib | Caprelsa | Tyrosine kinase inhibitor | Medullary thyroid cancer |
vernakalant | Brinavess | Atrial‑selective antiarrhythmic | Acute atrial fibrillation termination |
vilanterol | Breo Ellipta, Anoro Ellipta (combos) | Long‑acting beta2 agonist (LABA) | Maintenance therapy for COPD, asthma (combos) |
vecuronium | Norcuron | Non‑depolarizing neuromuscular blocker | Surgical muscle relaxation, intubation |
vigabatrin | Sabril | Irreversible GABA transaminase inhibitor | Infantile spasms, refractory epilepsy |
vismodegib | Erivedge | Hedgehog pathway inhibitor | Advanced basal cell carcinoma |
velaglucerase alfa | VPRIV | Recombinant enzyme replacement | Gaucher disease type 1 |
voretigene neparvovec | Luxturna | Gene therapy (AAV vector) | Inherited retinal dystrophy (RPE65 mutation) |
vibegron | Gemtesa | Beta3‑adrenergic agonist | Overactive bladder (urgency, frequency) |
volanesorsen | Waylivra | Antisense oligonucleotide | Familial chylomicronemia syndrome (EU) |
vinflunine | Javlor | Vinca‑derived microtubule inhibitor | Advanced urothelial carcinoma (some regions) |